We can’t show the full text here under this license. Use the link below to read it at the source.
Inhibition of STAT3 by 2-Methoxyestradiol suppresses M2 polarization and protumoral functions of macrophages in breast cancer
Blocking STAT3 with 2-Methoxyestradiol reduces tumor-supporting immune cells in breast cancer
AI simplified
Abstract
(2ME2) reduced the expression of several anti-inflammatory cytokines and growth factors associated with .
- Polarization of monocytes to M2 macrophages is linked to changes in the microtubule cytoskeleton.
- At lower concentrations, 2ME2 depolymerized microtubules and inhibited the polarization of macrophages to the M2 phenotype.
- 2ME2 significantly reduced the expression of CCL18, TGF-β, IL-10, FNT, arginase, CXCL12, MMP9, and VEGF-A.
- Treatment with 2ME2 hindered the metastasis-promoting effects of M2 macrophages.
- In an orthotopic breast cancer model, 2ME2 reduced CD163 expression in tumors and inhibited lung metastasis.
- 2ME2 treatment decreased the phosphorylation and nuclear translocation of STAT3, which was reversed by colivelin.
AI simplified
Key numbers
CD163 expression reduced
Decrease in M2 Marker Expression
treatment reduced CD163 levels in tumors.
Fewer metastatic lung nodules
Lung Metastasis Reduction
-treated mice showed reduced lung metastasis compared to controls.
Inhibition of pSTAT3
STAT3 Phosphorylation Inhibition
decreased phosphorylation of STAT3 in M2 macrophages.